oral semaglutide side effects Semaglutide: Double-edged Sword with Risks and Benefits GLP-1 meds have side effects….

Navigating the Titration Schedule Toward Maintenance The path to a maintenance dose is structured

Reported HPLC purity 99.49% Retention time 17.80 min Observed mass 4731.50 Da Batch APX-2026-0428-R The normalized Certificate of Analysis publishes only the lot-specific fields represented in the public record

Switching Switching rates were highest in January 2023 (3.0%, 3.0%, and 3.1% of the overall, T2D, and overweight/obesity populations, respectively)

Louisiana Patients Could Lose Access to GLP-1 Weight-Loss Drugs as Coverage Vanishes Highlights Louisiana state employees are already prohibited from using GLP-1s for weight loss despite $200 million annual spending on diabetes coverage Over 41 million Americans lost commercial insurance coverage for Wegovy in 2026, with major insurers eliminating coverage nationwide Four states, including California and Pennsylvania, eliminated Medicaid coverage for obesity treatment between October 2025 and January 2026 Louisiana Medicaid provides limited coverage for one non-GLP-1 weight-loss drug but restrictions remain tight Patients face monthly costs ranging from $936 to $1,349 without insurance coverage BATON ROUGE, La